A Robust Deep Learning Method with Uncertainty Estimation for the Pathological Classification of Renal Cell Carcinoma Based on CT Images.

Journal: Journal of imaging informatics in medicine
Published Date:

Abstract

This study developed and validated a deep learning-based diagnostic model with uncertainty estimation to aid radiologists in the preoperative differentiation of pathological subtypes of renal cell carcinoma (RCC) based on computed tomography (CT) images. Data from 668 consecutive patients with pathologically confirmed RCC were retrospectively collected from Center 1, and the model was trained using fivefold cross-validation to classify RCC subtypes into clear cell RCC (ccRCC), papillary RCC (pRCC), and chromophobe RCC (chRCC). An external validation with 78 patients from Center 2 was conducted to evaluate the performance of the model. In the fivefold cross-validation, the area under the receiver operating characteristic curve (AUC) for the classification of ccRCC, pRCC, and chRCC was 0.868 (95% CI, 0.826-0.923), 0.846 (95% CI, 0.812-0.886), and 0.839 (95% CI, 0.802-0.88), respectively. In the external validation set, the AUCs were 0.856 (95% CI, 0.838-0.882), 0.787 (95% CI, 0.757-0.818), and 0.793 (95% CI, 0.758-0.831) for ccRCC, pRCC, and chRCC, respectively. The model demonstrated robust performance in predicting the pathological subtypes of RCC, while the incorporated uncertainty emphasized the importance of understanding model confidence. The proposed approach, integrated with uncertainty estimation, offers clinicians a dual advantage: accurate RCC subtype predictions complemented by diagnostic confidence metrics, thereby promoting informed decision-making for patients with RCC.

Authors

  • Ni Yao
  • Hang Hu
    Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, IN, 47907, USA.
  • Kaicong Chen
    Department of Medical Imaging, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, China.
  • Huan Huang
    School of Information Science and Engineering, East China University of Science and Technology, Shanghai, 200237, China.
  • Chen Zhao
    Department of Ophthalmology, Fudan Eye & ENT Hospital, Shanghai, China.
  • Yuan Guo
    Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Boya Li
    Department of Medical Imaging, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, China.
  • Jiaofen Nan
    School of Computer and Communication Engineering, Zhengzhou University of Light Industry, Zhengzhou, Henan, China.
  • Yanting Li
    School of Computer and Communication Engineering, Zhengzhou University of Light Industry, Zhengzhou, 450001, China.
  • Chuang Han
    School of Electrical Engineering, Zhengzhou University, NO. 100 Kexue Road, Zhengzhou, Henan 450000, China.
  • Fubao Zhu
    School of Computer and Communication Engineering, Zhengzhou University of Light Industry, Zhengzhou, Henan, China.
  • Weihua Zhou
    School of Computing, University of Southern Mississippi, Hattiesburg, MS, United States of America.
  • Li Tian
    Department of Gastroenterology, Third Xiangya Hospital, Central South University, Changsha 410013, China. tianlixy3@csu.edu.cn.